Alerts will be sent to your verified email
Verify Email
CONCORD
|
Concord Drugs
|
Vaishali Pharma
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.78 % | 7.83 % | 9.47 % |
|
5yr average Equity Multiplier
|
1.87 | 2.48 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 0.88 | 1.46 |
|
5yr Avg Net Profit Margin
|
1.59 % | 3.68 % | 4.57 % |
|
Price to Book
|
2.99 | 1.53 | 1.22 |
|
P/E
|
178.46 | 0.0 | 14.94 |
|
5yr Avg Cash Conversion Cycle
|
233.27 Days | 87.63 Days | 5.37 Days |
|
Inventory Days
|
152.22 Days | 6.87 Days | 23.69 Days |
|
Days Receivable
|
106.22 Days | 177.19 Days | 65.58 Days |
|
Days Payable
|
74.71 Days | 159.49 Days | 89.52 Days |
|
5yr Average Interest Coverage Ratio
|
1.69 | 2.55 | 17.08 |
|
5yr Avg ROCE
|
8.41 % | 15.65 % | 13.68 % |
|
5yr Avg Operating Profit Margin
|
9.1 % | 5.99 % | 10.7 % |
|
5 yr average Debt to Equity
|
0.55 | 0.48 | 0.05 |
|
5yr CAGR Net Profit
|
-26.55 % | -4.82 % | 29.02 % |
|
5yr Average Return on Assets
|
1.46 % | 3.24 % | 6.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.39 % | 31.61 % | 38.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.39 % | 4.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Concord Drugs
|
Vaishali Pharma
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|